Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B

被引:0
作者
Ke Shi
Özlem Demir
Michael A. Carpenter
Jeff Wagner
Kayo Kurahashi
Reuben S. Harris
Rommie E. Amaro
Hideki Aihara
机构
[1] Molecular Biology and Biophysics,Department of Biochemistry
[2] University of Minnesota,Masonic Cancer Center
[3] University of Minnesota,Institute for Molecular Virology
[4] University of Minnesota,Department of Chemistry and Biochemistry
[5] University of California,Center for Genome Engineering
[6] University of Minnesota,Howard Hughes Medical Institute
[7] University of Minnesota,undefined
来源
Scientific Reports | / 7卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The APOBEC3B (A3B) single-stranded DNA (ssDNA) cytosine deaminase has important roles in innate immunity but is also a major endogenous source of mutations in cancer. Previous structural studies showed that the C-terminal catalytic domain of human A3B has a tightly closed active site, and rearrangement of the surrounding loops is required for binding to substrate ssDNA. Here we report structures of the A3B catalytic domain in a new crystal form that show alternative, yet still closed, conformations of active site loops. All-atom molecular dynamics simulations support the dynamic behavior of active site loops and recapitulate the distinct modes of interactions that maintain a closed active site. Replacing segments of A3B loop 1 to mimic the more potent cytoplasmic deaminase APOBEC3A leads to elevated ssDNA deaminase activity, likely by facilitating opening of the active site. These data collectively suggest that conformational equilibrium of the A3B active site loops, skewed toward being closed, controls enzymatic activity by regulating binding to ssDNA substrates.
引用
收藏
相关论文
共 119 条
  • [1] Harris RS(2015)APOBECs and virus restriction Virology 479–480C 131-145
  • [2] Dudley JP(2015)Intrinsic host restrictions to HIV-1 and mechanisms of viral escape Nat Immunol 16 546-53
  • [3] Simon V(2015)APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity Cancer Discov 5 704-12
  • [4] Bloch N(2014)Mechanisms underlying mutational signatures in human cancers Nat Rev Genet 15 585-98
  • [5] Landau NR(2014)Hypermutation in human cancer genomes: footprints and mechanisms Nat Rev Cancer 14 786-800
  • [6] Swanton C(2015)APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation Proc Natl Acad Sci USA 112 2841-6
  • [7] McGranahan N(2014)Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers Horm Cancer 5 405-13
  • [8] Starrett GJ(2016)The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer Sci Adv 2 e1601737-8
  • [9] Harris RS(2015)APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma Nat Commun 6 e1-25
  • [10] Helleday T(2015)High APOBEC3B expression is a predictor of recurrence in patients with low-risk clear cell renal cell carcinoma Urol Oncol 33 618-8